The Patent Finder

AbbVie Stemcentrx LLC

16 patents currently held · Updated Nov 22, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Feb 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 3, 2027
    The maintenance fee for Anti-DLL3 antibody drug conjugates (US 9,173,959) comes due May 3, 2027. Unpaid by Nov 3, 2027, it lapses early.
  • 1 fee due Nov 10, 2027
    The maintenance fee for Multivalent DLL3 antibodies (US 9,334,318) comes due Nov 10, 2027. Unpaid by May 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,534,058Anti-CD324 monoclonal antibodies and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 10,087,258Anti-CD324 monoclonal antibodies and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 9,409,995PTK7 modulators and methods of use
In force
 · USPTO record
In forceUSPTO record
US 10,836,831Anti-PTK7 antibodies and methods of use
In force
 · USPTO record
In forceUSPTO record
US 9,458,231Modulators and methods of use
In force
 · USPTO record
In forceUSPTO record
US 8,986,972Nucleic Acid Encoding DLL3 Antibodies
In force
 · Medium confidence
In forceMedium confidence
US 9,173,959Anti-DLL3 antibody drug conjugates
In force
 · USPTO record
In forceUSPTO record
US 9,334,318Multivalent DLL3 antibodies
In force
 · USPTO record
In forceUSPTO record
US 9,676,850Anti SEZ6 antibodies and methods of use
In force
 · USPTO record
In forceUSPTO record
US 11,033,634Light chain variable regions
In force
 · USPTO record
In forceUSPTO record
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
Also on record, not counted in the 16: 41 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 abandoned · 26 no status recorded

Showing 1 to 10 of 29, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/065,518Feb 27, 2025No status recorded
17/372,354Jul 9, 2021No status recorded
17/163,246Jan 29, 2021No status recorded
16/712,324Dec 12, 2019No status recorded
16/904,463May 30, 2019No status recorded
16/382,868Apr 12, 2019No status recorded
16/256,628Jan 24, 2019No status recorded
16/170,848Oct 25, 2018No status recorded
16/105,651Aug 20, 2018No status recorded
16/049,349Site-Specific Antibody Conjugation Methods and CompositionsJul 30, 2018Abandoned
10 of 29 applications shown.
Pro members see all 29 published applications.
Pro members: see all 29 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited